Institutional Ownership
Intra-Cellular Therapies Inc
CUSIP 46116X101COMITCIEURQ1 2026
13D / 13G Filings
30
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
30 filings · latest Jun 5, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jun 5, 2025 | Jpmorgan Chase &Amp; Co. | 13G/A | — | — | SEC |
| 2 | Feb 7, 2025 | Fmr LLC | 13G/A | 2.5% | 2.70M | SEC |
| 3 | Nov 12, 2024 | Fmr LLC | 13G/A | 10.5% | — | SEC |
| 4 | Nov 8, 2024 | Blackrock, Inc. | 13G/A | 5.9% | 6.22M | SEC |
| 5 | Oct 24, 2024 | Blackrock, Inc. | 13G/A | 5.9% | 6.22M | SEC |
| 6 | Oct 10, 2024 | Jpmorgan Chase & Co | 13G | 5.0% | 5.30M | SEC |
| 7 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.4% | 9.09M | SEC |
| 8 | Feb 9, 2024 | Wasatch Advisors LP | 13G/A | 3.8% | — | SEC |
| 9 | Feb 9, 2024 | Fmr LLC | 13G/A | 11.9% | — | SEC |
| 10 | Feb 8, 2024 | Wellington Management Group LLP | 13G/A | 1.8% | 1.76M | SEC |
20 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Intra-Cellular Therapies Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $2.5K |